Kyle Malady's Net Worth
Kyle Malady's net worth is estimated to be at least $4,650,673.86 as of 10/29/2025. CoreStreet's estimation of Kyle Malady's net worth is based on their sale of stock and current holding of stock.
Kyle Malady is Director at DexCom Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 667 units of DXCM stock on 09/05/2025. Their biggest sale was on 02/22/2024 when they sold 24,000 units of Verizon Communications Inc stock for $979,200.00. They typically trade 3 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $4,650,673.86
Most recent insider trade:
- Sept. 5, 2025
Kyle Malady's Insider Trading History
| DexCom Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 5, 2025 | Director | 667 | $80.86 | Sell | $53,933.62 |
| Verizon Communications Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 7, 2025 | CEO | 9,000 | $44.10 | Sell | $396,900.00 |
April 30, 2025 | CEO | 7,500 | $43.88 | Sell | $329,100.00 |
April 23, 2025 | CEO | 5,000 | $42.48 | Sell | $212,400.00 |
Feb. 3, 2025 | CEO | 8,000 | $39.88 | Sell | $319,040.00 |
Jan. 29, 2025 | CEO | 11,085 | $40.88 | Sell | $453,154.80 |
Jan. 27, 2025 | CEO | 20,000 | $40.54 | Sell | $810,800.00 |
Feb. 22, 2024 | CEO | 24,000 | $40.80 | Sell | $979,200.00 |
Feb. 15, 2024 | CEO | 15,000 | $40.33 | Sell | $604,950.00 |
March 15, 2023 | CEO | 6,226 | $36.69 | Sell | $228,431.94 |
March 13, 2023 | CEO | 7,199 | $36.50 | Sell | $262,763.50 |